Creating and sustaining fusion reactions—essentially recreating star-like conditions on Earth—is extremely difficult, and ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin.

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Reports Q3 revenue $72.6M, two estimates $72M. “Third quarter revenue increased sequentially and was above the midpoint of guidance, as recent ...

Net loss: Net loss for the fiscal first quarter of 2025, ending December 31, 2024, was $27.0 million, compared to a net loss of $61.5 million in the fiscal quarter ending December 31, 2023, ...